Céline Narjoz

1.7k total citations
42 papers, 1.1k citations indexed

About

Céline Narjoz is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Céline Narjoz has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Molecular Biology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Céline Narjoz's work include Colorectal Cancer Treatments and Studies (8 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Céline Narjoz is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Céline Narjoz collaborates with scholars based in France, Belgium and Switzerland. Céline Narjoz's co-authors include Philippe Beaune, Marie‐Anne Loriot, Isabelle de Waziers, Tarik Asselah, Rosette Lidereau, Patrick Marcellin, Sophie Vacher, Ivan Bièche, Laurent Chouchana and Xavier Roblin and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Céline Narjoz

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Céline Narjoz France 16 332 311 250 156 142 42 1.1k
Kelly K. Filipski United States 12 505 1.5× 195 0.6× 106 0.4× 170 1.1× 125 0.9× 26 1.1k
Mark A. Milad United States 15 175 0.5× 126 0.4× 189 0.8× 57 0.4× 94 0.7× 24 966
Cristi R. King United States 12 564 1.7× 379 1.2× 538 2.2× 93 0.6× 64 0.5× 17 1.2k
Christelle Cauffiez France 23 239 0.7× 720 2.3× 295 1.2× 123 0.8× 148 1.0× 60 1.5k
Huang Sm United States 12 329 1.0× 208 0.7× 359 1.4× 51 0.3× 94 0.7× 26 1.1k
Jason A. Sprowl United States 19 747 2.3× 315 1.0× 151 0.6× 93 0.6× 108 0.8× 34 1.2k
Nir I. Weijl Netherlands 16 418 1.3× 291 0.9× 53 0.2× 110 0.7× 244 1.7× 22 1.4k
Huixin Yu Netherlands 17 334 1.0× 315 1.0× 166 0.7× 34 0.2× 255 1.8× 33 1.1k
José M. Ladero Spain 27 386 1.2× 580 1.9× 742 3.0× 57 0.4× 62 0.4× 72 1.9k
Brigitte Tranchand France 22 556 1.7× 276 0.9× 107 0.4× 78 0.5× 152 1.1× 50 1.2k

Countries citing papers authored by Céline Narjoz

Since Specialization
Citations

This map shows the geographic impact of Céline Narjoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Narjoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Narjoz more than expected).

Fields of papers citing papers by Céline Narjoz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Narjoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Narjoz. The network helps show where Céline Narjoz may publish in the future.

Co-authorship network of co-authors of Céline Narjoz

This figure shows the co-authorship network connecting the top 25 collaborators of Céline Narjoz. A scholar is included among the top collaborators of Céline Narjoz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Narjoz. Céline Narjoz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zaanan, Aziz, et al.. (2024). A fatal case of 5-FU toxicity despite dose adjustment in a patient with a partial DPD deficiency receiving the FLOT regimen. European Journal of Cancer. 205. 114102–114102.
2.
Narjoz, Céline, et al.. (2024). Diagnostic Yield of APOL1 p.N264K Variant Screening in Daily Practice. Kidney International Reports. 9(6). 1916–1918. 1 indexed citations
3.
Ferron, Pierre‐Jean, Romain Pelletier, Julie Massart, et al.. (2024). Role of CYP2D6 polymorphisms in tramadol metabolism in a context of co-medications and overweight. Food and Chemical Toxicology. 196. 115192–115192.
4.
Launay, Manon, Bernard Royer, Jérôme Guitton, et al.. (2022). Quantitative impact of pre‐analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency. British Journal of Clinical Pharmacology. 89(2). 762–772. 15 indexed citations
5.
Puszkiel, Alicja, Céline Narjoz, Jennifer Arrondeau, et al.. (2022). Exposure–Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer. Pharmaceutics. 14(9). 1844–1844. 18 indexed citations
6.
Étienne-Grimaldi, Marie-Christine, Nicolas Pallet, Valérie Boige, et al.. (2022). Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency. European Journal of Cancer. 181. 3–17. 19 indexed citations
7.
Philippe, Aurélien, Céline Narjoz, Nicolas Gendron, et al.. (2022). Imbalance between alpha-1-antitrypsin and interleukin 6 is associated with in-hospital mortality and thrombosis during COVID-19. Biochimie. 202. 206–211. 9 indexed citations
8.
Thomas, Fabienne, Manon Launay, Camille Tron, et al.. (2021). Artificial increase of uracilemia during fluoropyrimidine treatment can lead to DPD deficiency misinterpretation. Annals of Oncology. 32(6). 810–811. 11 indexed citations
9.
Narjoz, Céline, et al.. (2021). Pretherapeutic screening for Dihydropyrimidine deshydrogenase deficiency in measuring uracilemia in dialysis patients leads to a high rate of falsely positive results. Cancer Chemotherapy and Pharmacology. 88(6). 1049–1053. 12 indexed citations
10.
Narjoz, Céline, et al.. (2020). Identification of Rare Defective Allelic Variants in Cases of Thiopurine S-Methyltransferase Deficient Activity. Pharmacogenomics. 21(17). 1217–1226. 5 indexed citations
11.
Pallet, Nicolas, Simon Garinet, Hélène Blons, et al.. (2020). A comprehensive population-based study comparing the phenotype and genotype in a pretherapeutic screen of dihydropyrimidine dehydrogenase deficiency. British Journal of Cancer. 123(5). 811–818. 36 indexed citations
12.
Martin, Elodie, Céline Narjoz, Xavier Declèves, et al.. (2019). Dextromethorphan Analgesia in a Human Experimental Model of Hyperalgesia. Anesthesiology. 131(2). 356–368. 10 indexed citations
13.
Noé, Gaëlle, Olivier Huillard, Lisa Golmard, et al.. (2016). Relation between plasma trough concentration of abiraterone and prostate-specific antigen response in metastatic castration-resistant prostate cancer patients. European Journal of Cancer. 72. 54–61. 49 indexed citations
14.
Gouin‐Thibault, Isabelle, Xavier Delavenne, Anne Blanchard, et al.. (2016). Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin. Journal of Thrombosis and Haemostasis. 15(2). 273–283. 106 indexed citations
15.
Étienne-Grimaldi, Marie-Christine, Fabienne Thomas, Sylvie Quaranta, et al.. (2015). UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice. Fundamental and Clinical Pharmacology. 29(3). 219–237. 84 indexed citations
16.
Narjoz, Céline, Michael Montemurro, William D. Figg, et al.. (2014). Important Role of CYP2J2 in Protein Kinase Inhibitor Degradation: A Possible Role in Intratumor Drug Disposition and Resistance. PLoS ONE. 9(5). e95532–e95532. 28 indexed citations
17.
Kofman, Tomek, Vincent Audard, Céline Narjoz, et al.. (2014). APOL1 Polymorphisms and Development of CKD in an Identical Twin Donor and Recipient Pair. American Journal of Kidney Diseases. 63(5). 816–819. 39 indexed citations
18.
Boudou‐Rouquette, Pascaline, Céline Narjoz, Jean Louis Golmard, et al.. (2012). Early Sorafenib-Induced Toxicity Is Associated with Drug Exposure and UGTIA9 Genetic Polymorphism in Patients with Solid Tumors: A Preliminary Study. PLoS ONE. 7(8). e42875–e42875. 85 indexed citations
19.
Chouchana, Laurent, et al.. (2011). Screening of TPMT Deficiency by Phenotyping and Genotyping: A Retrospective Study Among 1,500 IBD Patients in France. Gastroenterology. 140(5). S–281. 2 indexed citations
20.
Bièche, Ivan, Céline Narjoz, Tarik Asselah, et al.. (2007). Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenetics and Genomics. 17(9). 731–742. 263 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelly K. Filipski Breakdown of academic impact, for papers by Mark A. Milad Breakdown of academic impact, for papers by Cristi R. King Breakdown of academic impact, for papers by Christelle Cauffiez Breakdown of academic impact, for papers by Huang Sm Breakdown of academic impact, for papers by Jason A. Sprowl Breakdown of academic impact, for papers by Nir I. Weijl Breakdown of academic impact, for papers by Huixin Yu Breakdown of academic impact, for papers by José M. Ladero Breakdown of academic impact, for papers by Brigitte Tranchand
Rankless by CCL
2026